Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00075517 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: docetaxel
DRUG: gemcitabine hydrochloride

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group